Request Sample Inquiry
Plasma Therapy Market

Plasma Therapy Market

Plasma Therapy Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

141

Base Year:

2022

Date

Aug - 2023

Format:

PDF XLS PPT

Report Code:

VMR-2256

Segments Covered
  • By Type By Type Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin, Hyperbaric Oxygen Therapy (HBOT), Combined Plasma Therapy with Stem Cells, Other Types
  • By Source By Source Autologous, Allogenic
  • By Application By Application Orthopedics, Dermatology, Hematology, Neurology, Immunology, Dental, Other Applications
  • By End User By End User Hospitals, Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa, Latin America
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 359.8 Billion
Revenue 2030Revenue 2030: USD 653.5 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 13.9%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Plasma Therapy Market - Segment Analysis
    1. Overview
    2. Global Plasma Therapy Market, 2016 - 2028 (USD Million)
    3. Global Plasma Therapy Market - by Type
      1. By Pure PRP
      2. By Leukocyte-Rich PRP
      3. By Pure Platelet-Rich Fibrin
      4. By Leukocyte-Rich Fibrin
      5. By Hyperbaric Oxygen Therapy (HBOT)
      6. By Combined Plasma Therapy with Stem Cells
      7. By Other Types
    4. Global Plasma Therapy Market - by Source
      1. By Autologous
      2. By Allogenic
    5. Global Plasma Therapy Market - by Application
      1. By Orthopedics
      2. By Dermatology
      3. By Hematology
      4. By Neurology
      5. By Immunology
      6. By Dental
      7. By Other Applications
    6. Global Plasma Therapy Market - by End User
      1. By Hospitals
      2. By Clinics
      3. By Ambulatory Surgical Centers
      4. By Research Institutes
      5. By Other End-Users
    7. Global Plasma Therapy Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    8. Market comparative analysis
  4. North America Plasma Therapy Market - Segment Analysis
    1. Overview
    2. North America Plasma Therapy Market, 2016 - 2028 (USD Million)
    3. North America Plasma Therapy Market, by Type
      1. By Pure PRP
      2. By Leukocyte-Rich PRP
      3. By Pure Platelet-Rich Fibrin
      4. By Leukocyte-Rich Fibrin
      5. By Hyperbaric Oxygen Therapy (HBOT)
      6. By Combined Plasma Therapy with Stem Cells
      7. By Other Types
    4. North America Plasma Therapy Market, by Source
      1. By Autologous
      2. By Allogenic
    5. North America Plasma Therapy Market, by Application
      1. By Orthopedics
      2. By Dermatology
      3. By Hematology
      4. By Neurology
      5. By Immunology
      6. By Dental
      7. By Other Applications
    6. North America Plasma Therapy Market, by End User
      1. By Hospitals
      2. By Clinics
      3. By Ambulatory Surgical Centers
      4. By Research Institutes
      5. By Other End-Users
    7. North America Plasma Therapy Market, by Country
      1. U.S.
        1. U.S. Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. U.S. Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. U.S. Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. U.S. Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      2. Canada
        1. Canada Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Canada Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Canada Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Canada Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      3. Mexico
        1. Mexico Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Mexico Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Mexico Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Mexico Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
  5. Europe Plasma Therapy Market - Segment Analysis
    1. Overview
    2. Europe Plasma Therapy Market, 2016 - 2028 (USD Million)
    3. Europe Plasma Therapy Market, by Type
      1. By Pure PRP
      2. By Leukocyte-Rich PRP
      3. By Pure Platelet-Rich Fibrin
      4. By Leukocyte-Rich Fibrin
      5. By Hyperbaric Oxygen Therapy (HBOT)
      6. By Combined Plasma Therapy with Stem Cells
      7. By Other Types
    4. Europe Plasma Therapy Market, by Source
      1. By Autologous
      2. By Allogenic
    5. Europe Plasma Therapy Market, by Application
      1. By Orthopedics
      2. By Dermatology
      3. By Hematology
      4. By Neurology
      5. By Immunology
      6. By Dental
      7. By Other Applications
    6. Europe Plasma Therapy Market, by End User
      1. By Hospitals
      2. By Clinics
      3. By Ambulatory Surgical Centers
      4. By Research Institutes
      5. By Other End-Users
    7. Europe Plasma Therapy Market, by Country
      1. Germany
        1. Germany Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Germany Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Germany Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Germany Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      2. UK
        1. UK Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. UK Market, By Source
          1. By Autologous
          2. By Allogenic
        3. UK Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. UK Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      3. France
        1. France Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. France Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. France Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. France Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      4. Spain
        1. Spain Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Spain Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Spain Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Spain Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      5. Italy
        1. Italy Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Italy Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Italy Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Italy Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      6. BENELUX
        1. BENELUX Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. BENELUX Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. BENELUX Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. BENELUX Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      7. Rest of Europe
        1. Rest Of Europe Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Rest Of Europe Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Rest Of Europe Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Rest Of Europe Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
  6. Asia Pacific Plasma Therapy Market - Segment Analysis
    1. Overview
    2. Asia Pacific Plasma Therapy Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Plasma Therapy Market, by Type
      1. By Pure PRP
      2. By Leukocyte-Rich PRP
      3. By Pure Platelet-Rich Fibrin
      4. By Leukocyte-Rich Fibrin
      5. By Hyperbaric Oxygen Therapy (HBOT)
      6. By Combined Plasma Therapy with Stem Cells
      7. By Other Types
    4. Asia Pacific Plasma Therapy Market, by Source
      1. By Autologous
      2. By Allogenic
    5. Asia Pacific Plasma Therapy Market, by Application
      1. By Orthopedics
      2. By Dermatology
      3. By Hematology
      4. By Neurology
      5. By Immunology
      6. By Dental
      7. By Other Applications
    6. Asia Pacific Plasma Therapy Market, by End User
      1. By Hospitals
      2. By Clinics
      3. By Ambulatory Surgical Centers
      4. By Research Institutes
      5. By Other End-Users
    7. Asia Pacific Plasma Therapy Market, by Country
      1. China
        1. China Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. China Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. China Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. China Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      2. Japan
        1. Japan Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Japan Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Japan Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Japan Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      3. India
        1. India Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. India Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. India Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. India Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      4. South Korea
        1. South Korea Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. South Korea Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. South Korea Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. South Korea Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      5. South East Asia
        1. South East Asia Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. South East Asia Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. South East Asia Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. South East Asia Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Rest of Asia Pacific Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Rest of Asia Pacific Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Rest of Asia Pacific Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
  7. Latin America Plasma Therapy Market - Segment Analysis
    1. Overview
    2. Latin America Plasma Therapy Market, 2016 - 2028 (USD Million)
    3. Latin America Plasma Therapy Market, by Type
      1. By Pure PRP
      2. By Leukocyte-Rich PRP
      3. By Pure Platelet-Rich Fibrin
      4. By Leukocyte-Rich Fibrin
      5. By Hyperbaric Oxygen Therapy (HBOT)
      6. By Combined Plasma Therapy with Stem Cells
      7. By Other Types
    4. Latin America Plasma Therapy Market, by Source
      1. By Autologous
      2. By Allogenic
    5. Latin America Plasma Therapy Market, by Application
      1. By Orthopedics
      2. By Dermatology
      3. By Hematology
      4. By Neurology
      5. By Immunology
      6. By Dental
      7. By Other Applications
    6. Latin America Plasma Therapy Market, by End User
      1. By Hospitals
      2. By Clinics
      3. By Ambulatory Surgical Centers
      4. By Research Institutes
      5. By Other End-Users
    7. Latin America Plasma Therapy Market, by Country
      1. Brazil
        1. Brazil Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Brazil Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Brazil Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Brazil Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      2. Argentina
        1. Argentina Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Argentina Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Argentina Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Argentina Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      3. Rest of Latin America
        1. Rest of Latin America Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Rest of Latin America Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Rest of Latin America Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Rest of Latin America Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
  8. Middle East & Africa Plasma Therapy Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Plasma Therapy Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Plasma Therapy Market, by Type
      1. By Pure PRP
      2. By Leukocyte-Rich PRP
      3. By Pure Platelet-Rich Fibrin
      4. By Leukocyte-Rich Fibrin
      5. By Hyperbaric Oxygen Therapy (HBOT)
      6. By Combined Plasma Therapy with Stem Cells
      7. By Other Types
    4. Middle East & Africa Plasma Therapy Market, by Source
      1. By Autologous
      2. By Allogenic
    5. Middle East & Africa Plasma Therapy Market, by Application
      1. By Orthopedics
      2. By Dermatology
      3. By Hematology
      4. By Neurology
      5. By Immunology
      6. By Dental
      7. By Other Applications
    6. Middle East & Africa Plasma Therapy Market, by End User
      1. By Hospitals
      2. By Clinics
      3. By Ambulatory Surgical Centers
      4. By Research Institutes
      5. By Other End-Users
    7. Middle East & Africa Plasma Therapy Market, by Country
      1. GCC Countries
        1. GCC Countries Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. GCC Countries Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. GCC Countries Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. GCC Countries Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      2. South Africa
        1. South Africa Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. South Africa Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. South Africa Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. South Africa Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Plasma Therapy Market, By Type
          1. By Pure PRP
          2. By Leukocyte-Rich PRP
          3. By Pure Platelet-Rich Fibrin
          4. By Leukocyte-Rich Fibrin
          5. By Hyperbaric Oxygen Therapy (HBOT)
          6. By Combined Plasma Therapy with Stem Cells
          7. By Other Types
        2. Rest of Middle East & Africa Plasma Therapy Market, By Source
          1. By Autologous
          2. By Allogenic
        3. Rest of Middle East & Africa Plasma Therapy Market, By Application
          1. By Orthopedics
          2. By Dermatology
          3. By Hematology
          4. By Neurology
          5. By Immunology
          6. By Dental
          7. By Other Applications
        4. Rest of Middle East & Africa Plasma Therapy Market, By End User
          1. By Hospitals
          2. By Clinics
          3. By Ambulatory Surgical Centers
          4. By Research Institutes
          5. By Other End-Users
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Cambryn Biologics LLC (U.S.)
    2. BioLife Plasma Services (U.S.)
    3. CSL Ltd. (Australia)
    4. Biotest Pharmaceuticals (Germany)
    5. Kedrion S.P.A. (Italy)
    6. Grifols International S.A. (Spain)
    7. China Biologic Products Inc. (China)
    8. LFB Plasma (U.S.)
    9. Octapharma Plasma Inc. (Switzerland)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 31-Aug-2023
Plasma Therapy Market to Reach Valuation of USD 653.5 Billion by 2030 – Growth in the Usage of Automated Plasma Collection Systems and Advancements in Processing Techniques Drive the Market
FAQ
Frequently Asked Question

  • The global Plasma Therapy valued at USD 359.8 Billion in 2022 and is expected to reach USD 653.5 Billion in 2030 growing at a CAGR of 13.9%.

  • The prominent players in the market are Cambryn Biologics LLC (U.S.), BioLife Plasma Services (U.S.), CSL Ltd. (Australia), Biotest Pharmaceuticals (Germany), Kedrion S.P.A. (Italy), Grifols International S.A. (Spain), China Biologic Products Inc. (China), LFB Plasma (U.S.), Octapharma Plasma Inc. (Switzerland).

  • The market is project to grow at a CAGR of 13.9% between 2023 and 2030.

  • The driving factors of the Plasma Therapy include

    • Rising Incidences of Sports Injuries

  • North America was the leading regional segment of the Plasma Therapy in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy